Capstone Development Services Company

Capstone Development Services Company is a strategic investor specializing in healthcare. The company leads development, manages regulatory services, and ensures the timely approval of healthcare products through partnerships with global pharmaceutical and medical companies. To date, Capstone has developed and obtained regulatory approval for 18 products in the United States, the European Union, and Canada. The company also has two products pending regulatory approval to support its partners in bringing new, affordable healthcare products to market.